SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-057106
Filing Date
2024-05-09
Accepted
2024-05-09 16:31:15
Documents
74
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q snse-20240331.htm   iXBRL 10-Q 1587749
2 EX-10.1 snse-ex10_1.htm EX-10.1 25159
3 EX-10.2 snse-ex10_2.htm EX-10.2 200560
4 EX-10.4 snse-ex10_4.htm EX-10.4 26442
5 EX-31.1 snse-ex31_1.htm EX-31.1 14798
6 EX-31.2 snse-ex31_2.htm EX-31.2 14763
7 EX-32.1 snse-ex32_1.htm EX-32.1 8613
8 GRAPHIC img138987672_0.jpg GRAPHIC 759
  Complete submission text file 0000950170-24-057106.txt   7057928

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT snse-20240331.xsd EX-101.SCH 1157981
78 EXTRACTED XBRL INSTANCE DOCUMENT snse-20240331_htm.xml XML 875504
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39980 | Film No.: 24931265
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)